PL3909956T3 - 1,5-Hydrat soli chlorowodorkowej pochodnej heterocyklicznej - Google Patents
1,5-Hydrat soli chlorowodorkowej pochodnej heterocyklicznejInfo
- Publication number
- PL3909956T3 PL3909956T3 PL21180717.7T PL21180717T PL3909956T3 PL 3909956 T3 PL3909956 T3 PL 3909956T3 PL 21180717 T PL21180717 T PL 21180717T PL 3909956 T3 PL3909956 T3 PL 3909956T3
- Authority
- PL
- Poland
- Prior art keywords
- hydrate
- hydrochloride salt
- derivative compound
- heterocyclic derivative
- heterocyclic
- Prior art date
Links
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 title 1
- -1 heterocyclic derivative compound Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C63/00—Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings
- C07C63/04—Monocyclic monocarboxylic acids
- C07C63/06—Benzoic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C63/00—Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings
- C07C63/04—Monocyclic monocarboxylic acids
- C07C63/06—Benzoic acid
- C07C63/10—Halides thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/96—Esters of carbonic or haloformic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20170064914 | 2017-05-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3909956T3 true PL3909956T3 (pl) | 2025-04-07 |
Family
ID=64396846
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL18806513T PL3632917T3 (pl) | 2017-05-25 | 2018-05-24 | Sposób wytwarzania pochodnych heterocyklicznych |
| PL21180717.7T PL3909956T3 (pl) | 2017-05-25 | 2018-05-24 | 1,5-Hydrat soli chlorowodorkowej pochodnej heterocyklicznej |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL18806513T PL3632917T3 (pl) | 2017-05-25 | 2018-05-24 | Sposób wytwarzania pochodnych heterocyklicznych |
Country Status (25)
| Country | Link |
|---|---|
| US (6) | US20200207784A1 (pl) |
| EP (3) | EP3632917B1 (pl) |
| JP (4) | JP2020521007A (pl) |
| KR (1) | KR102307504B1 (pl) |
| CN (3) | CN119143779A (pl) |
| AU (1) | AU2018273020B2 (pl) |
| CA (2) | CA3150710C (pl) |
| DK (1) | DK3909956T3 (pl) |
| EA (1) | EA201992801A1 (pl) |
| ES (2) | ES3011357T3 (pl) |
| FI (1) | FI3909956T3 (pl) |
| HR (1) | HRP20250183T1 (pl) |
| HU (1) | HUE070148T2 (pl) |
| IL (2) | IL294127B2 (pl) |
| LT (1) | LT3909956T (pl) |
| MX (2) | MX393863B (pl) |
| MY (1) | MY201054A (pl) |
| NZ (2) | NZ780383A (pl) |
| PH (1) | PH12019502418B1 (pl) |
| PL (2) | PL3632917T3 (pl) |
| PT (1) | PT3909956T (pl) |
| SI (1) | SI3909956T1 (pl) |
| TW (2) | TWI837089B (pl) |
| WO (1) | WO2018217050A1 (pl) |
| ZA (1) | ZA201908433B (pl) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2021079225A (ja) * | 2021-03-01 | 2021-05-27 | 株式会社三洋物産 | 遊技機 |
| JP2021087836A (ja) * | 2021-03-01 | 2021-06-10 | 株式会社三洋物産 | 遊技機 |
| JP7556432B2 (ja) * | 2022-08-22 | 2024-09-26 | 株式会社三洋物産 | 遊技機 |
| JP7556434B2 (ja) * | 2022-08-22 | 2024-09-26 | 株式会社三洋物産 | 遊技機 |
| JP7556433B2 (ja) * | 2022-08-22 | 2024-09-26 | 株式会社三洋物産 | 遊技機 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6197291A (ja) * | 1984-10-17 | 1986-05-15 | Yamanouchi Pharmaceut Co Ltd | ７−〔α−（２−アミノ−４−チアゾリル）−α−（低級アルコキシイミノ）アセトアミド〕−３−〔６−（２Ｈ−ピリド〔４，３−ｂ〕−１，４−オキサジニオ）メチル〕−Δ３−セフエム−４−カルボキシレ−トおよびその製造法 |
| IL119466A (en) | 1995-11-03 | 2001-08-26 | Akzo Nobel Nv | Thrombin inhibitors, their preparation and pharmaceutical compositions containing them |
| JP3988832B2 (ja) * | 2004-11-29 | 2007-10-10 | 日本たばこ産業株式会社 | 窒素含有縮合環化合物及びその用途 |
| AR051780A1 (es) | 2004-11-29 | 2007-02-07 | Japan Tobacco Inc | Compuestos en anillo fusionados que contienen nitrogeno y utilizacion de los mismos |
| JP4646068B2 (ja) * | 2005-09-30 | 2011-03-09 | 国立大学法人東京工業大学 | ポジ型感光性樹脂組成物、その製造方法、及びレリーフパターンの形成方法 |
| US20080305169A1 (en) * | 2006-05-26 | 2008-12-11 | Japan Tobacco Inc. | Pharmaceutical Compositions Comprising Nitrogen-Containing Fused Ring Coumpounds |
| US20080064871A1 (en) * | 2006-05-26 | 2008-03-13 | Japan Tobacco Inc. | Production Method of Nitrogen-Containing Fused Ring Compounds |
| WO2008062740A1 (fr) * | 2006-11-20 | 2008-05-29 | Japan Tobacco Inc. | Composé azoté à anneaux fusionnés et son utilisation |
| MY155517A (en) | 2008-03-31 | 2015-10-30 | C&C Res Lab | Heterocyclic derivatives |
| EP2281128B1 (en) * | 2008-04-28 | 2019-08-28 | Robert Bosch GmbH | Drive belt ring component and manufacturing method and maraging steel base material therefor |
-
2018
- 2018-05-24 US US16/615,566 patent/US20200207784A1/en not_active Abandoned
- 2018-05-24 IL IL294127A patent/IL294127B2/en unknown
- 2018-05-24 EP EP18806513.0A patent/EP3632917B1/en active Active
- 2018-05-24 PL PL18806513T patent/PL3632917T3/pl unknown
- 2018-05-24 CA CA3150710A patent/CA3150710C/en active Active
- 2018-05-24 ES ES21180717T patent/ES3011357T3/es active Active
- 2018-05-24 PL PL21180717.7T patent/PL3909956T3/pl unknown
- 2018-05-24 HR HRP20250183TT patent/HRP20250183T1/hr unknown
- 2018-05-24 JP JP2020516362A patent/JP2020521007A/ja not_active Withdrawn
- 2018-05-24 CN CN202411028089.2A patent/CN119143779A/zh active Pending
- 2018-05-24 NZ NZ780383A patent/NZ780383A/en unknown
- 2018-05-24 PT PT211807177T patent/PT3909956T/pt unknown
- 2018-05-24 WO PCT/KR2018/005932 patent/WO2018217050A1/ko not_active Ceased
- 2018-05-24 MY MYPI2019006799A patent/MY201054A/en unknown
- 2018-05-24 CN CN202111329839.6A patent/CN114085235B/zh active Active
- 2018-05-24 PH PH1/2019/502418A patent/PH12019502418B1/en unknown
- 2018-05-24 CA CA3061301A patent/CA3061301C/en active Active
- 2018-05-24 CN CN201880034458.5A patent/CN110691783A/zh active Pending
- 2018-05-24 ES ES18806513T patent/ES2907590T3/es active Active
- 2018-05-24 LT LTEP21180717.7T patent/LT3909956T/lt unknown
- 2018-05-24 FI FIEP21180717.7T patent/FI3909956T3/fi active
- 2018-05-24 TW TW107117713A patent/TWI837089B/zh active
- 2018-05-24 TW TW112144614A patent/TW202411234A/zh unknown
- 2018-05-24 AU AU2018273020A patent/AU2018273020B2/en active Active
- 2018-05-24 NZ NZ758513A patent/NZ758513A/en unknown
- 2018-05-24 DK DK21180717.7T patent/DK3909956T3/da active
- 2018-05-24 MX MX2019013937A patent/MX393863B/es unknown
- 2018-05-24 IL IL270789A patent/IL270789B2/en unknown
- 2018-05-24 SI SI201831214T patent/SI3909956T1/sl unknown
- 2018-05-24 EP EP21180716.9A patent/EP3909955A1/en active Pending
- 2018-05-24 KR KR1020197032941A patent/KR102307504B1/ko active Active
- 2018-05-24 EP EP21180717.7A patent/EP3909956B1/en active Active
- 2018-05-24 HU HUE21180717A patent/HUE070148T2/hu unknown
- 2018-05-24 EA EA201992801A patent/EA201992801A1/ru unknown
-
2019
- 2019-11-21 MX MX2022005722A patent/MX2022005722A/es unknown
- 2019-12-18 ZA ZA2019/08433A patent/ZA201908433B/en unknown
-
2022
- 2022-06-14 JP JP2022095779A patent/JP7557500B2/ja active Active
- 2022-07-07 US US17/859,566 patent/US11866448B2/en active Active
- 2022-07-07 US US17/859,603 patent/US12497410B2/en active Active
-
2023
- 2023-09-26 US US18/372,856 patent/US12103938B2/en active Active
- 2023-11-01 US US18/386,093 patent/US12030895B2/en active Active
-
2024
- 2024-07-10 JP JP2024110726A patent/JP2024129160A/ja active Pending
- 2024-07-10 JP JP2024110729A patent/JP7796815B2/ja active Active
-
2025
- 2025-11-14 US US19/389,519 patent/US20260070923A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL289793A (en) | Heterocyclic compounds as ret kinase inhibitors | |
| IL276509A (en) | Heterocyclic compounds as kinase inhibitors | |
| ZA202003778B (en) | Heterocyclic compounds as prmt5 inhibitors | |
| SG11202005112TA (en) | Heterocyclic compounds as prmt5 inhibitors | |
| HRP20221051T8 (hr) | Heterociklički spojevi kao inhibitori ret kinaze | |
| IL280821A (en) | Heterocycline compound | |
| LT3909956T (lt) | Heterociklinio darinio junginio hidrochlorido druskos 1,5 hidratas | |
| ZA202104402B (en) | Heterocyclic compound | |
| IL266789A (en) | Heterocyclic compounds as kinase inhibitors | |
| SG11202009356RA (en) | Heterocyclic compound | |
| PT3643718T (pt) | Composto heterocíclico e seu uso como modulador alostérico positivo do recetor muscarínico colinérgico m1 | |
| ZA201907792B (en) | Heterocyclic compound | |
| GB201806488D0 (en) | Heterocyclic TADF compounds | |
| IL277340A (en) | The orthocyclic compound | |
| AU2024203236A1 (en) | Heterocyclic compounds as RET kinase inhibitors | |
| ZA201907793B (en) | Heterocyclic compound | |
| GB201808580D0 (en) | Heterocyclic compounds | |
| HK1260208A1 (en) | Heterocyclic compounds as ret kinase inhibitors |